이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Mochida Pharmaceutical 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Naoyuki Mochida

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	25.7yrs
CEO 소유권	3.1%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	4.3yrs

최근 관리 업데이트

Recent updates

CEO

Naoyuki Mochida

25.7yrs

테뉴어

Mr. Naoyuki Mochida is President of Mochida Pharmaceutical Co., Ltd. from January 1999 and serves as its Representative Director since January 1999. Mr. Mochida joined the Mochida Pharmaceutical Co., Ltd....

이사회 구성원

이름	위치	테뉴어	보상	소유권
Naoyuki Mochida	President & Representative Director	25.7yrs	데이터 없음	3.1% ¥ 3.8b
Masayoshi Takeda	GM, Head of Finance & Accounting Department and Full-Time Audit & Supervisory Board Member	2.3yrs	데이터 없음	0.0031% ¥ 3.8m
Keiichi Sagisaka	Senior Executive Managing Officer of Pharmaceutical Business & Healthcare and Director	14.3yrs	데이터 없음	데이터 없음
Chu Sakata	Senior EVP & Representative Director	13.3yrs	데이터 없음	0.042% ¥ 50.8m
Junichi Sakaki	Senior Exec Managing Officer of Business Development	10.3yrs	데이터 없음	0.029% ¥ 35.7m
Yutaka Kawakami	Executive Managing Officer	5.3yrs	데이터 없음	0.017% ¥ 20.2m
Motoi Mitsuishi	Member of the Board & Executive Managing Officer	1.7yrs	데이터 없음	0.0017% ¥ 2.1m
Nana Otsuki	Independent Outside Director	3.3yrs	데이터 없음	0.0014% ¥ 1.7m
Tomoo Kugisawa	Independent Outside Director	12.3yrs	데이터 없음	0.010% ¥ 12.7m
Tomoaki Sonoda	Independent Outside Director	2.3yrs	데이터 없음	0.0014% ¥ 1.7m
Shigeaki Yoshikawa	Independent Outside Director	1.7yrs	데이터 없음	0.00085% ¥ 1.0m
Mami Kobayashi	Outside Director	less than a year	데이터 없음	데이터 없음

4.3yrs

평균 재임 기간

경험이 풍부한 이사회: 4534 의 이사회는 경험(평균 재직 기간 7 년)으로 간주됩니다.

Mochida Pharmaceutical 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Mochida Pharmaceutical Co., Ltd., Annual General Meeting, Jun 27, 2024

Mochida Pharmaceutical Co., Ltd., Annual General Meeting, Jun 29, 2023

Less than half of directors are independent

Mochida Pharmaceutical Co., Ltd., Annual General Meeting, Jun 29, 2022

Less than half of directors are independent

Recent updates

Upcoming dividend of JP¥40.00 per share

New major risk - Revenue and earnings growth

Mochida Pharmaceutical (TSE:4534) Will Pay A Dividend Of ¥40.00

Mochida Pharmaceutical Co., Ltd. to Report Q2, 2025 Results on Nov 01, 2024

Mochida Pharmaceutical (TSE:4534) Is Paying Out A Dividend Of ¥40.00

Mochida Pharmaceutical (TSE:4534) Will Pay A Dividend Of ¥40.00

First quarter 2025 earnings released: EPS: JP¥43.84 (vs JP¥46.23 in 1Q 2024)

Now 24% undervalued

Mochida Pharmaceutical (TSE:4534) Is Paying Out A Dividend Of ¥40.00

Mochida Pharmaceutical (TSE:4534) Will Pay A Dividend Of ¥40.00

Final dividend of JP¥40.00 announced

Mochida Pharmaceutical Co., Ltd. to Report Q1, 2025 Results on Aug 02, 2024

Full year 2024 earnings: EPS exceeds analyst expectations

Mochida Pharmaceutical Co., Ltd., Annual General Meeting, Jun 27, 2024

Mochida Pharmaceutical's (TSE:4534) Dividend Will Be ¥40.00

Upcoming dividend of JP¥40.00 per share

Mochida Pharmaceutical (TSE:4534) Will Pay A Dividend Of ¥40.00

Mochida Pharmaceutical Co., Ltd. to Report Fiscal Year 2024 Results on May 13, 2024

Third quarter 2024 earnings released: EPS: JP¥45.16 (vs JP¥112 in 3Q 2023)

Consensus EPS estimates fall by 28%

Mochida Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Mochida Pharmaceutical Co., Ltd. to Report Q3, 2024 Results on Feb 05, 2024

Second quarter 2024 earnings released: EPS: JP¥32.02 (vs JP¥20.52 in 2Q 2023)

Upcoming dividend of JP¥40.00 per share at 2.4% yield

Mochida Pharmaceutical Co., Ltd. to Report Q2, 2024 Results on Nov 02, 2023

First quarter 2024 earnings released: EPS: JP¥46.23 (vs JP¥83.98 in 1Q 2023)

Mochida Pharmaceutical Co., Ltd. to Report Q1, 2024 Results on Aug 04, 2023

Full year 2023 earnings: EPS and revenues miss analyst expectations

Mochida Pharmaceutical Co., Ltd., Annual General Meeting, Jun 29, 2023

Upcoming dividend of JP¥40.00 per share at 2.5% yield

Third quarter 2023 earnings released: EPS: JP¥112 (vs JP¥138 in 3Q 2022)

Mochida Pharmaceutical Co., Ltd. to Report Q3, 2023 Results on Feb 06, 2023

Second quarter 2023 earnings released: EPS: JP¥20.52 (vs JP¥59.14 in 2Q 2022)

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥20.52 (vs JP¥59.14 in 2Q 2022)

Upcoming dividend of JP¥40.00 per share

Mochida Pharmaceutical Co., Ltd. to Report Q2, 2023 Results on Nov 04, 2022

First quarter 2023 earnings released: EPS: JP¥83.98 (vs JP¥69.33 in 1Q 2022)

Mochida Pharmaceutical Co., Ltd. (TSE:4534) announces an Equity Buyback for 1,190,000 shares, representing 3.17% for ¥3,500 million.

Mochida Pharmaceutical Co., Ltd. to Report Q1, 2023 Results on Aug 01, 2022

Full year 2022 earnings: EPS exceeds analyst expectations

Mochida Pharmaceutical Co., Ltd., Annual General Meeting, Jun 29, 2022

Less than half of directors are independent

Mochida Pharmaceutical Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥40.00 per share

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Second quarter 2022 earnings released: EPS JP¥59.13 (vs JP¥52.74 in 2Q 2021)

Upcoming dividend of JP¥40.00 per share

First quarter 2022 earnings released: EPS JP¥69.33 (vs JP¥86.88 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥222 (vs JP¥118 in FY 2020)

Upcoming dividend of JP¥40.00 per share

New 90-day high: JP¥4,305

New 90-day high: JP¥4,265

Third quarter 2021 earnings released: EPS JP¥77.56 (vs JP¥45.66 in 3Q 2020)

Revenue and earnings beat expectations

Mochida Pharmaceutical Co., Ltd. to Report Q3, 2021 Results on Feb 05, 2021

CEO

테뉴어

이사회 구성원

평균 재임 기간